Efficacy and Safety of TQB2618 Injection Combined With Toripalimab Injection in Patients With Advanced Melanoma

NCT05451407 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma

Interventions

DRUG: TQB2618 injection
DRUG: Toripalimab injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.